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Summary
Background/aims:  A  few  recent  reports  have  demonstrated  an  elevated  prevalence
of  latent  tuberculosis  infection  (LTBI)  among  laboratory  personnel.  We  sought  to
evaluate  the  prevalence  of  LTBI  among  laboratory  personnel  using  the  QuantiFERON-
TB  Gold  In-Tube  (QFT-GIT)  assay  and  to  assess  the  risk  factors  associated  with  positive
test  results.
Methods:  The  study  population  included  laboratory  personnel  who  were  working
in  the  routine  diagnostic  laboratories  of  different  departments  of  a  university  hos-
pital.  Subjects  were  interviewed  using  a  standardized  questionnaire  that  assessed
information  related  to  risk  factors  for  LTBI  and  underwent  the  QFT-GIT  assay.
Results:  Positive  QFT-GIT  tests  results  were  detected  in  19.4%  (26/134)  of
the  laboratory  personnel.  The  following  factors  were  signiﬁcantly  associated
with  positive  QFT-GIT  results:  age  ≥  30  years  [odds  ratio  (OR):  4.741,  95%  CI:
1.41—17.50,  P  =  0.004];  duration  of  employment  in  the  healthcare  profession  >10
years  (P  <  0.0001);  and  non-Saudi  nationality  (OR:  21.67,  95%  CI:  6.69—73.94,
P  <  0.0001).
Abbreviations: LTBI, latent tuberculosis infection; TST, tuberculin skin test; MTB, Mycobacterium tuberculosis; BCG, Bacillus
almette-Guérin; NTM, non-tuberculous mycobacteria; RD1, region of difference; IFN-, interferon gamma; IGRAs, interferon gamma
elease assays; ESAT-6, early secreted antigenic target 6; CFP-10, culture ﬁltrate protein 10; CDC, Centers for Disease Control and
revention; HCWs, health care workers; QFT-GIT, QuantiFERON-TB Gold In-Tube; OR, odds ratio; CI, conﬁdence interval.
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Introduction
Tuberculosis  in  Saudi  Arabia  is  still  not  fully  con-
trolled,  despite  the  enormous  efforts  exerted  by
the Ministry  of  Health.  Saudi  Arabia  is  still  a coun-
try in  the  intermediate  prevalence  category  [1].
Several factors  may  play  vital  roles  in  the  ongoing
transmission of  TB  in  Saudi  Arabia,  including  a  high
number  of  expatriates,  the  Hajj  pilgrimage,  Omra,
and the  social  habits  of  Saudi  citizens.
The current  treatment  strategy  for  active  TB  is
inadequate  for  disease  elimination,  partially  due
to latent  TB  infections  (LTBIs).  It  has  been  esti-
mated that  one-third  of  the  world  population  has
an LTBI  [2], with  an  annual  risk  of  0.1%  of  devel-
oping active  TB  [3]. Therefore,  identifying  and
treating  latently  infected  subjects  who  are  at  an
increased  risk  of  progressing  to  active  disease  are
key elements  of  TB  control  programs  [4].  Such
preventive treatment  diminishes  the  risk  of  subse-
quently  developing  active  TB  by  approximately  90%
[5].
Over  the  last  century,  the  tuberculin  skin  test
(TST) has  been  the  traditional  testing  method
for the  diagnosis  of  LTBI  in  different  popula-
tions throughout  the  world  [6].  However,  the
TST has  many  limitations.  The  test  uses  a rela-
tively crude  mix  of  antigens  from  Mycobacterium
tuberculosis  (MTB);  as  a  result,  false-positive
reactions can  occur  because  of  previous  Bacillus
Calmette-Guérin  (BCG)  vaccination  or  sensitization
to non-tuberculous  mycobacteria  (NTM)  [7].
To overcome  the  relatively  low  speciﬁcity  asso-
ciated with  the  TST,  antigens  encoded  in  the  region
of difference  (RD1)  of  the  MTB  genome  were  used
to develop  T  lymphocyte-based  interferon  (IFN)-
release  assays  (IGRAs),  which  became  commer-
cially available  in  2005.  IGRAs  measure  the  cellular
immune  responses  to  a  few  MTB-speciﬁc  antigens,
including  early  secreted  antigenic  target  6 (ESAT-6)
and culture  ﬁltrate  protein  10  (CFP-10)  of  the  RD1
in comparison  with  the  mixed  non-speciﬁc  antigens
used in  the  TST  [8].
IGRAs  are  standardized,  quality-controlled  labo-
ratory  tests  that  provide  results  within  24  h.  They
have excellent  speciﬁcity  and  are  unaffected  by
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light  the  need  for  effective  institutional  TB  infection
our  data  reinforce  the  necessities  of  pre-employment
f  laboratory  personnel  and  the  importance  of  offering
ive  subjects  to  prevent  the  progression  to  active  disease.
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CG  and  NTM  [7,9].  Unlike  the  TST,  they  require  a
ingle patient  visit,  the  result  is  read  by an  instru-
ent and,  thus,  is  objective,  and  they  do  not  have
 ‘booster’  effect.  IGRAs  appear  to  be  at  least  as
ensitive  as  the  TST  [7].
IGRAs may  seem  too  expensive  at  ﬁrst  glance.
owever, taking  into  account  the  expense  of
ollow-up examinations  due  to  false-positive  TST
esults, the  overall  cost  associated  with  IGRA
creening is  fairly  acceptable.  The  use  of  IGRAs
s steadily  increasing  in  low  or  intermediate  inci-
ence countries.  In  2005  and  in  2010,  the  US  Centers
or Disease  Control  and  Prevention  (CDC)  recom-
ended  that  IGRAs  be  used  in  all  situations  in  which
he TST  is  currently  used  [10].
Health  care  workers  (HCWs)  have  been  known
o be  at  a high  risk  for  TB  infections  due  to  occu-
ational exposures  to  patients  with  TB  infections
r specimens  with  MTB  [11]. Additionally,  HCWs
re at  a  particular  risk  for  the  progression  to
B disease  [12]. Regarding  the  prevalence  of  LTBI
mong HCWs,  few  studies  have  been  conducted
n high  or  intermediate  incidence  settings.  Fur-
hermore,  many  of  these  studies  used  the  TST
nd were  thus  hampered  by  its  low  speciﬁcity  and
ts cross  reactivity  with  BCG  and  NTM  infections
13].
According  to  Saudi  national  policy,  as  well  as
ountries  of  East  Asia,  from  which  most  of  the  expa-
riates  are  always  recruited,  all  infants  are  required
o be  vaccinated  with  BCG.  The  usefulness  of  the
ST in  detecting  LTBI  is  therefore  limited  due  to
he possibility  of  false  positives  as  a  result  of  BCG
accination  [7].
A few  recent  reports  showed  a higher  preva-
ence of  LTBI  in  laboratory  personnel  than  in  other
CWs, but  they  included  only  a  limited  number  of
aboratory  personnel  [8,11,14]. There  has  been  no
arge-scale  study  that  speciﬁcally  focused  on  the
ssue of  LTBI  in  laboratory  personnel  who  have  a
igh level  of  exposure  to  specimens  from  patients
ith TB.  This  study  was  undertaken  to  evaluate
he prevalence  of  LTBI  among  laboratory  person-
el at  a university  hospital  using  IGRAs  and  to
ssess the  risk  factors  related  to  positive  test
esults.
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aterials and methods
tudy design
 cross  sectional  comparative  survey  was  con-
ucted.  The  study  protocol  was  approved  by  the
nstitutional  ethics  committee.
tudy population
ll  laboratory  personnel  (technologist  and  super-
isors)  afﬁliated  with  the  routine  diagnostic
aboratories  at  a  university  hospital  in  eastern
audi Arabia  during  the  time  of  the  study  were
nvited to  participate  in  the  study.  The  routine
iagnostic laboratories  included  the  departments
f microbiology,  immunology/serology,  and  hema-
ology/blood  bank.  The  study  was  conducted  over
 period  of  6  months  (January  2012—June  2012).
he total  number  of  subjects  available  for  the  study
as 156.  The  number  of  participants  after  applying
he exclusion  criteria  was  149,  while  seven  subjects
ere  excluded  from  the  study.  Ten  personnel  were
nrolled  in  a  pilot  study  then  excluded  from  the
tudy. Thus,  the  participants  of  the  study  were  139
aboratory  personnel.
Exclusion  criteria  included  a  positive  history  of
ctive TB,  a  history  of  household  contact  with  TB
atients,  clinical  evidence  of  active  TB,  and  the  use
f immunosuppressive  drugs.
Study objectives  and  procedures  were  explained
o each  of  the  study  participants,  and  it  was  clearly
xplained  to  participants  that  the  results  would
e conﬁdential.  A  written  informed  consent  was
btained  from  each  participant  prior  to  inclusion
n the  study.
All participants  were  interviewed  using  a stan-
ardized questionnaire,  and  data  were  collected
y the  researcher  [15]. The  questionnaire  provided
nformation on  possible  risk  factors  for  LTBI,  includ-
ng data  on  age,  sex,  nationality,  education  level,
resent  workplace,  duration  of  work  in  the  health-
are profession,  and  any  history  of  previous  TST.
The questionnaire  was  reviewed  by  an  expert
anel for  suitability  and  efﬁcacy.  A  pilot  study  was
onducted  on  10  randomly  selected  personnel  who
ere excluded  from  the  main  study.
nterferon- release assay
or  the  IGRA,  the  QuantiFERON-TB  Gold  In-
ube (QFT-GIT)  test  was  used  according  to  the
anufacturer’s protocol  (Cellestis  Ltd.,  Carnegie,
ustralia). In  brief,  venipuncture  was  performed
nd 3  ml  of  whole  blood  was  collected  into  three
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-ml  heparinized  tubes.  One  tube  served  as  the
egative  control  containing  only  heparin.  The  sec-
nd tube  served  as  the  positive  control  containing
he T  cell  mitogen  phytohemagglutinin,  and  the
hird tube  included  the  peptides  ESAT-6,  CFP-
0 and  TB7.7.  After  being  incubated  upright  at
7 ◦C  for  24  h,  the  specimens  were  centrifuged  at
000—3000  rpm  for  15  min.  The  supernatant  was
rozen  at  −20 ◦C  for  further  analysis.  The  release
f IFN-  in  response  to  MTB  peptides  was  mea-
ured by  an  enzyme-linked  immunosorbent  assay.
he results  were  calculated  using  the  QFT  soft-
are.  The  result  was  considered  positive  if  the
FN- was  at  least  0.35  IU/ml.  It  was  considered
ndeterminate  if  the  corrected  IFN-  release  for
uberculin-speciﬁc  antigen  was  less  than  0.35  IU/ml
nd the  positive  control  for  mitogen  was  less  than
.5 IU/ml.
tatistical analysis
ata  were  entered  in  computer  using  SPSS  for  win-
ows version  17.0  (SPSS  Inc.,  Chicago,  IL).  The
ata were  described  using  the  frequency,  the  dis-
ribution, the  mean,  and  the  standard  deviation.
nivariate analyses  were  conducted  using  the  Chi-
quare test  and  Fisher’s  exact  test  for  qualitative
ariables. The  odds  ratio  (95%  CI)  was  calculated
o quantify  the  risk  of  different  factors.  The  signif-
cance  of  the  results  was  at  5%.
esults
 total  of  139  laboratory  personnel  joined  the  study.
ue to  indeterminate  QFT-GIT  assay  results,  ﬁve
ere excluded  from  the  analysis.  Baseline  char-
cteristics  of  the  study  participants  are  shown  in
able  1. Their  mean  age  was  33.0  ±  9.2  years,
ith a range  of  21—60  years.  Males  constituted
3.7% of  the  study  participants  (72  participants).
he mean  duration  of  work  in  the  health  care
rofession was  6.9  ±  7.9  years,  with  a range  of
.08—37.0 years.  The  highest  contribution  was
rom the  microbiology  department  (59  subjects,
4%). Participants  from  other  departments  included
1 laboratory  technicians  from  the  immunol-
gy/serology  and  hematology/blood  bank  labs.
here were  14  trainees  who  rotated  between  dif-
erent laboratory  sections,  spending  two  months
n each  department  (non-mutually  exclusive).  The
ajority of  the  study  population  (97  participants,
2.4%) had  Saudi  nationality.  East  Asians  were
he most  frequent  non-Saudi  participants  (34/134,
5.4%).  The  QFT-GIT  was  positive  in  19.4%  (26)  of
he study  participants.
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Table  1  Characteristics  of  the  study  participants.
Characteristic  No.  (%)
Age  (years):  range
(mean  ±  SD)
21—60  (33.0 ±  9.2)
Gender
Male  72  (53.7)
Female  62  (46.3)
Duration  of  work  (years):
range  (mean  ±  SD)
0.08—37.0  (6.9  ±  7.9)
Workplace
Microbiology  department  59  (44.0)
Non-microbiology
departments
61  (45.5)
Trainees  (rotators)  14  (10.5)
Nationality
Saudi  97  (72.4)
East  Asia  34  (25.4)
Middle  East  3  (2.2)
TST  history
Negative  TST  in  medical
history
28  (20.9)
Positive  TST  in  medical
history
8  (6.0)
No  TST  in  medical  history 86  (64.1)
Not  sure  about  TST  in
medical  history
12  (9.0)
Results
Negative  108  (80.6)
Positive  26  (19.4)
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Table  2  Correlation  between  QFT-GIT  positivity  and  socio-
of  the  study  participants.
Item  Categories  Positivi
Gender  Male  16/72  (
Female  10/62  (
Age  20—29  4/54  (7
≥30  22/80  (
Duration  of  work  ≤2  0/47  (0
2—5  4/31  (1
6—10  6/32  (1
>10  16/24  (
Workplace  Micro  11/59  (
Non-micro  15/61  (
Trainee  0/14  (0
Nationality  Saudi  6/97  (6
Non-Saudi  20/34  (
TST  status  Positive  TST  in  medical  history  3/8  (37
Negative  TST  in  medical  history  5/28  (1
No  TST  in  medical  history  12/86  (
2, Chi-square test; FA, Fisher’s exact test; NA, OR is undeﬁned.
* Statistically signiﬁcant at P ≤ 0.05.M.I.  Hassan,  A.E.  Diab
Risk  factors  for  a  positive  QFT-GIT  test  were  ana-
yzed.  Positive  QFT-GIT  results  were  signiﬁcantly
ssociated with  the  non-Saudi  nationality  (OR:
1.67,  95%  CI:  6.69—73.94,  P  <  0.0001).  An  age  ≥  30
ears was  associated  with  an  increased  risk  of
FT-GIT  positivity  (OR:  4.741,  95%  CI:  1.41—17.50,
 =  0.004),  as  well  as  duration  of  work  in  healthcare
ervice (P  <  0.0001).  Trainees  (n  =  14),  who  rotated
etween  different  laboratory  sections,  were  all
egative for  the  QFT-GIT  (Table  2). No  statistically
igniﬁcant association  was  observed  between  test
ositivity and  gender,  workplace  or the  TST  status
f the  study  participants,  after  excluding  those  who
ere not  sure  about  their  status  from  the  analysis.
iscussion
he  global  burden  of  TB  remains  enormous,  with
n estimated  8.7  million  new  cases  and  1.4  mil-
ion deaths  in  2011  [16]. Furthermore,  it  has  been
stimated  that  one  third  of  the  world  population
as LTBI  [2], and  approximately  10%  of  LTB-infected
ubjects will  progress  to  active  TB  during  their
ifetime [17]. The  importance  of  increasing  the
peciﬁcity  for  the  diagnostic  tests  lies  in  reduc-
ng LTBI  overestimation,  subsequently  reducing  the
asted resources  on  treating  false  positives;  these
esources  could  instead  be  allocated  to  latently
nfected subjects.  In addition,  using  the  more  spe-
iﬁc IGRAs  would  save  HCWs  and  other  TB  contacts
demographic  data,  the  work  history  and  the  TST  status
ty,  no.  (%)  OR  (95%  CI)  Signiﬁcance
22.2)  1
16.1)  0.67  (0.26—1.75)  2 =  0.79  P  =  0.374
.4)  1
27.5)  4.741  (1.41—17.50)* 2 =  8.32  P  =  0.004*
.0)  1
2.9)  NA FEP  =  0.022*
8.8)  NA FEP  =  0.003*
66.7)  NA  2 =  40.45P <  0.0001*
42.3)  1
57.7)  1.42  (0.55—3.75)  2 =  0.62  P  =  0.429
.0)  0.0 FEP  =  0.109
.2)  1
54.1)  21.67  (6.69—73.94)* 2 =  43.85P <  0.0001*
.5)  1
7.9)  0.36  (0.05—2.76) FEP  =  0.338
14.0)  0.27  (0.05—1.66) FEP  =  0.113
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Tatent  tuberculosis  in  laboratory  personnel  
rom  unnecessary  follow-up  and  potential  adverse
ffects  of  chemotherapy.  With  the  IGRAs,  we  have,
or the  ﬁrst  time,  a  test  that  allows  for  valid  state-
ents  regarding  the  LTBI  prevalence.  The  use  of
GRAs is  increasingly  recommended,  particularly  in
CG-vaccinated  populations  [18].
Recently,  a  few  large-scale  studies  addressed  the
revalence  of  LTBI  among  HCWs,  and  it  was  found  to
e signiﬁcantly  higher  than  in  the  general  popula-
ion [19—21].  Although  laboratory  technicians  were
ncluded in  these  studies,  the  exact  prevalence  in
aboratory personnel  was  not  reported  [20,21]. A
igher prevalence  of  LTBI  in  laboratory  personnel
han in  other  HCWs  was  demonstrated  in  few  stud-
es [8,14]. However,  only  limited  data  on  this  issue
re available  in  the  literature.  Additionally,  to  the
est of  our  knowledge,  this  is  the  ﬁrst  study  in
audi Arabia  focusing  on  laboratory  personnel.  We
etected a  prevalence  of  19.4%  (26/134)  of  QFT-
IT positivity.  Comparing  our  results  with  the  few
ata in  the  literature,  the  prevalence  of  LTBI  among
aboratory  personnel  were  found  to  be  21.4%  in
orea [15],  19%  in  Japan  [11], and  54%  in  India  [8],
hree countries  that  represent  intermediate,  low,
nd high  incidence  settings,  respectively.  Bearing
n mind  that  Saudi  Arabia  is  an  intermediate  TB
urden  country,  the  data  show  that  the  prevalence
f IGRA  positivity  in  laboratory  personnel  would  be
ependent  on  the  incidence  of  TB  in  the  general
opulation.
In the  present  study,  the  prevalence  of  LTBI
ssessed by  QFT-GIT  correlated  signiﬁcantly  with
ge. In  the  subgroup  with  participants  under  30
ears old,  the  LTBI  prevalence  was  7.4%,  while
n the  subgroup  with  participants  above  30,  the
revalence  increased  to  27.5%.  Similar  results  were
btained  from  Germany,  Portugal,  and  French  HCWs
hen the  youngest  and  oldest  age  categories  were
ompared  [22].  The  higher  LTBI  prevalence  in  older
articipants  might  be  explained  by  longer  exposure
ime  at  work  or  by  a  cohort  effect.  We  also  observed
hat the  length  of  work  in  the  healthcare  sector
as a  signiﬁcant  predictor  for  LTBI,  which  might
eﬂect the  cumulative  exposure  to  TB.  The  signif-
cant correlation  between  the  level  of  IFN-  and
oth age  (P  =  0.004)  and  the  length  of  employment
P < 0.0001)  detected  in  the  present  study  was  in
greement  with  many  other  studies  [15,19,20,23].
Especially  in  ﬁelds  with  an  increased  risk  of  TB
xposure, effective  control  measures  are  important
ools to  reduce  TB  transmission.  Moon  et  al.  found
hat working  in  sections  of  the  laboratory  with  a
omparatively  higher  risk  was  a  signiﬁcant  risk  fac-
or for  LTBI  [15].  Other  investigators  documented
he higher  prevalence  of  LTBI  among  HCWs  who
orked in  departments  with  increased  contact  with
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B  patients  [23,24]. In  the  present  study,  however,
o statement  could  be  made  regarding  the  occupa-
ional  risk  when  comparing  the  results  of different
aboratory sections.  Similarly,  Schablon  et  al.,  who
nvestigated  LTBI  in  healthcare  sector  employees  in
ermany, observed  no  statistically  signiﬁcant  asso-
iation of  IGRA  positivity  with  the  workplace  [20].
ecause of  the  inadequate  data  in  the  literature,  it
s difﬁcult  to  evaluate  the  tuberculosis  risk  in  differ-
nt laboratory  sections.  Risk  variability  according
o the  laboratory  sections  might  indicate  the  dif-
erent degree  of  exposure  intensity.  Although  the
icrobiology  section  deals  more  frequently  than
thers with  specimen  processing,  such  as  centrifu-
ation  and  inoculation,  working  in  microbiology
aboratory was  not  a predictor  for  IGRA  positivity  in
his study.  This  could  be  explained  by  the  fact  that
he microbiology  laboratory  is  dealing  with  cultures
nd isolates  of  infectious  organisms,  which  renders
aboratory  personnel  working  there  more  familiar
ith the  appropriate  protective  measures.
In this  study,  the  prevalence  of  QFT-GIT  posi-
ivity was  signiﬁcantly  associated  with  non-Saudi
ationalities (P  < 0.0001),  of  which  the  East  Asian
ationality  constituted  a majority.  In  Riyadh,  the
revalence  of  LTBI  among  two-year  new  hires  of
CWs was  investigated.  The  highest  signiﬁcant  posi-
ive TST  rates  were  found  among  HCWs  coming  from
ub-Saharan  countries  (61.1%)  compared  with  Saudi
CWs with  the  lowest  positive  rates  (5%)  as  a  ref-
rence group  [25]. Unfortunately,  even  though  the
ajority of  expatriates  are  from  endemic  places,
TBI screening  is  not  implemented  in  many  health-
are institutes  among  the  routine  tests  given  to
ewly hired  employees.
We  observed  no  statistically  signiﬁcant  asso-
iations with  gender,  workplace  or  TST  status.
e found  no  positive  IGRA  results  among  the  14
rainees  who  rotated  between  different  laboratory
ections, which  could  be  explained  by  the  short
uration of  exposure.
According  to  the  CDC  guidelines,  HCWs  who  are
ossibly  exposed  to  persons  with  TB  disease  or  to
linical specimens  that  might  contain  MTB  are  clas-
iﬁed as  medium  risk  in  terms  of  the  TB  screening
rogram [4].  They  should  receive  baseline  TB
creening  when  hired  and  a follow-up  screening
nnually [4]. Furthermore,  the  treatment  of  LTBI
mong HCWs  should  be  encouraged  to  prevent  the
rogression  to  TB  disease  [12]. Although  Saudi  Ara-
ia is  a  country  with  intermediate  prevalence  of
B [1],  regular  screening  of  HCWs,  including  lab-
ratory personnel,  for  LTBI  is  not  being  strictly
dhered to.  This  might  be  due  to  the  inaccuracy
nd inconvenience  of  the  TST.  Although  IGRA  would
e reliable  and  easy  to  perform  in  BCG-vaccinated
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populations,  its  higher  cost  was  regarded  as  a bar-
rier against  routine  screening.  Nevertheless,  recent
studies  reported  that  IGRA  was  feasible  and  cost-
effective  [26,27].
Very  few  studies  have  been  performed  on  disease
progression in  IGRA  positive  individuals  [28,29]. The
data indicated  that  the  progression  rate,  within  the
103 weeks  of  observation,  for  IGRA  positive  subjects
(14.6%)  was  higher  than  the  rate  for  TST  positive
subjects estimated  by  the  same  investigators  (2.3%)
[28],  as  well  as  the  rate  estimated  by  the  WHO  [30]
for  a  lifetime  after  a  positive  TST  (5—10%).
Several  limitations  in  our  study  had  to  be
addressed. First,  a  larger  number  of  participants
are needed  to  improve  the  signiﬁcance  of  testing.
Second, the  population  is  a  mixture  of  many  nation-
alities  with  different  patterns  of  exposure  and
different  patterns  of  TB  prevalence.  Finally,  this
study is  a  cross-sectional  evaluation  for  the  preva-
lence of  LTBI,  and  serial  changes  or  the  conversion
of QFT-GIT  over  time  could  not  be  evaluated.  Thus,
we have  a  limitation  on  the  distinction  between
recent and  previous  exposure.
Conclusion
In conclusion,  this  study  is  one  of  the  few  studies
on the  prevalence  of  LTBI  among  laboratory  per-
sonnel.  The  data  obtained  demonstrated  that  the
prevalence  of  QFT-GIT  positivity  in  laboratory  per-
sonnel would  be  dependent  on  the  incidence  of  TB
in the  general  population.  The  putative  risk  factors
for QFT-GIT  positivity  could  be  age,  the  duration
of work  in  the  health  care  profession  as  well  as  a
non-Saudi  nationality.  Our  data  emphasize  the  need
to design  and  implement  a  simple,  effective,  and
affordable  institutional  TB  infection-control  plan  to
prevent LTBI  among  laboratory  personnel.  Addition-
ally,  we  emphasize  the  necessity  of  screening  for
LTBI both  as  a  routine  pre-employment  investiga-
tion and  as  a  part  of  periodic  HCWs  checkups.  This
will support  TB  control  through  chemoprophylaxis
and prevent  cross-infection.  Larger  cohort  studies
are needed  to  evaluate  the  individual  risks  of  active
TB development  in  latently  infected  subjects  and
the effectiveness  of  preventive  therapy  based  on
IFN- test  results.
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